Market revenue in 2023 | USD 174.1 million |
Market revenue in 2030 | USD 276.6 million |
Growth rate | 6.8% (CAGR from 2023 to 2030) |
Largest segment | Clot retrievers |
Fastest growing segment | Aspiration/Suction Devices |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clot Retrievers, Aspiration/Suction Devices, Vascular Snares |
Key market players worldwide | Medtronic PLC, Acandis GmbH, Stryker Corp, Penumbra Inc, Phenox, Vesalio |
Clot retrievers was the largest segment with a revenue share of 59.05% in 2024. Horizon Databook has segmented the Asia Pacific neurothrombectomy devices market based on clot retrievers, aspiration/suction devices, vascular snares covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific neurothrombectomy devices market is majorly driven by increasing incidence of acute ischemic stroke. In addition, emerging economies such as China, Japan, South Korea, and India are expected to witness considerable growth over the forecast period.
Presence of several local players in China and Japan may also boost the market growth. However, certain developing countries in this region are expected to witness moderate growth rate over the forecast period. Low adoption of advanced healthcare facilities and a lack of skilled professionals in such countries may hinder the market growth.
Furthermore, low rate of awareness among people regarding the treatment of acute ischemic stroke, mechanical thrombectomy & intravenous thrombolysis, and low healthcare reimbursement facilities in developing countries are also anticipated to restrain the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account